A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults

The American Journal of Emergency Medicine
Richard M NowakXOPENEX Acute Severe Asthma Study Group

Abstract

This multicenter, randomized, double-blind trial compared nebulized levalbuterol (Lev) and racemic albuterol (Rac) in the treatment of acute asthma. Adults with acute asthma exacerbations (FEV(1) 20%-55% predicted) received prednisone and either Lev (1.25 mg, n = 315) or Rac (2.5 mg, n = 312). Nebulized treatments were administered every 20 minutes in the first hour, then every 40 minutes for 3 additional doses, then as necessary for up to 24 hours. The primary end point was time to meet discharge criteria. Secondary end points included changes in lung function and hospitalization rates. A subset of 160 patients had plasma (S)-albuterol concentrations determined at study entry. Time to meet discharge criteria did not differ between the 2 treatments. FEV(1) improvement was greater following Lev compared with Rac, both after dose 1 and cumulatively over the entire treatment period (dose 1 in intent to treat [ITT] group: Lev 0.50 +/- 0.43 L, Rac 0.43 +/- 0.37 L; P = .02), particularly among the 60% of patients not on recent steroid therapy (dose 1: Lev 0.58 +/- 0.47 L, Rac 0.44 +/- 0.37 L; P < .01), and patients whose entry (S)-albuterol concentrations were in the highest quartile of those measured. A small and similar proportion ...Continue Reading

References

Dec 1, 1995·The American Journal of Medicine·E R McFaddenT Hammons
Jan 1, 1996·Clinical Reviews in Allergy & Immunology·J Morley
Feb 1, 1997·American Journal of Respiratory and Critical Care Medicine·L StraussE R McFadden
Aug 4, 1998·The American Journal of Medicine·E R McFaddenL Dixon
Nov 6, 1998·Pulmonary Pharmacology & Therapeutics·A G TempletonD A Handley
Dec 16, 1998·The Journal of Allergy and Clinical Immunology·H S NelsonP D Rubin
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·R StanfordL J Okamoto
Aug 19, 1999·The Journal of Allergy and Clinical Immunology·C P Page, J Morley
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·R DhandM J Tobin
Dec 23, 1999·Current Opinion in Pulmonary Medicine·D A HandleyM E Snider
May 8, 2001·International Archives of Allergy and Immunology·S H ChoC K Oh
Oct 29, 2002·The American Journal of Medicine·Ellen J WeberCarlos A Camargo
Oct 3, 2003·American Journal of Respiratory and Critical Care Medicine·E R McFadden
Jan 16, 2004·The American Journal of Emergency Medicine·Richard M NowakJames M Roach
Mar 10, 2004·The Journal of Allergy and Clinical Immunology·Devendra K AgrawalPeter W Kelbe
Jul 1, 2005·Annals of Emergency Medicine·Faiqa QureshiBonnie L Burke
Jul 2, 2005·The Journal of Allergy and Clinical Immunology·Bill T Ameredes, William J Calhoun

❮ Previous
Next ❯

Citations

Jun 6, 2007·Current Allergy and Asthma Reports·H William Kelly
Aug 13, 2009·Current Allergy and Asthma Reports·Bill T Ameredes, William J Calhoun
Oct 25, 2006·American Journal of Respiratory and Critical Care Medicine·Bill T Ameredes, William J Calhoun
May 20, 2011·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Bradley Chipps
Apr 2, 2011·Expert Opinion on Pharmacotherapy·Manish Patel, Neil C Thomson
Jul 19, 2006·Current Medical Research and Opinion·William E BergerUNKNOWN Xopenex Pediatric Asthma Group
May 8, 2015·Lung India : Official Organ of Indian Chest Society·Ritesh AgarwalSubhash Varma
Dec 5, 2012·Pulmonary Pharmacology & Therapeutics·Kana Ram Jat, Anju Khairwa
May 26, 2009·The Journal of Pediatrics·Timothy AndrewsJoseph J Zorc
Feb 19, 2008·The Journal of Emergency Medicine·Michael J Matteucci, David A Tanen
Jul 15, 2009·Pediatric Pulmonology·Maroun J MhannaRobert Cohn
Jul 29, 2006·Expert Opinion on Pharmacotherapy·Henry Milgrom
Jul 1, 2007·Current Therapeutic Research, Clinical and Experimental·Maroun J MhannaRobert C Cohn
Jun 11, 2016·Journal of Veterinary Internal Medicine·M G ArroyoK M Ivester
Feb 9, 2008·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Mihai-Sergiu Jalba
Jan 15, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Glenn A JacobsonE Haydn Walters
Aug 25, 2019·Journal of Clinical Medicine·Eirini KostakouNikoletta Rovina
Sep 22, 2015·Journal of Clinical Pharmacology·David F Lehmann, Sarabeth Wojnowicz
Jan 24, 2007·COPD·James F DonohueUNKNOWN Levalbuterol COPD Study Group
Mar 1, 2012·Expert Opinion on Pharmacotherapy·Manish Patel, Neil C Thomson
Aug 23, 2019·Clinical Pharmacokinetics·Nienke J VetMatthijs de Hoog
May 12, 2018·The Journal of Allergy and Clinical Immunology. in Practice·Alan P Baptist, Paula J Busse
Mar 31, 2020·The American Journal of Emergency Medicine·Brit LongMichael Gottlieb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.